Biotechnology News

July 4, 2014

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion in a referral procedure...

July 3, 2014

MORRISTOWN, N.J.--(BUSINESS WIRE)--QPharma, a leading regulatory compliance and brand solutions company, has expanded its call center offerings with the addition of an Aggregate Spend Call Center solution for life sciences companies. “As...

July 3, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO), an innovative Company specialized in the development of drugs in orphan oncology diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted...

July 3, 2014

EVRY, France & MUNICH--(BUSINESS WIRE)--Regulatory News: Global Bioenergies (Paris:ALGBE) (Alternext Paris : ALGBE) and the Fraunhofer Center for Chemical-Biotechnological Processes announced today that they have signed the contract for the...

July 3, 2014

MEMPHIS, Tenn.--(BUSINESS WIRE)--MicroPort Orthopedics Inc. (“MPO”) and MB Innovations (“MBI”) announced today that the two firms have entered into a multi-product development agreement for orthopedic instruments. MBI will initially provide...

July 3, 2014

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”)(OTCBB:ACTC), a leader in the field of regenerative medicine, today announced that it has entered into a $30 million common stock purchase agreement with Lincoln Park...

July 3, 2014

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group (NYSE MKT: XXII) announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for technology that decreases or increases nicotine in tobacco plants.

July 3, 2014

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that the Company has filed a citizen petition (CP) regarding the approvability of purported generic versions of COPAXONE®. Teva submitted this CP...

July 3, 2014

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus expects to file its 10-Q for the 3rd quarter of fiscal year 2014 on Tuesday, July 8. A conference call to discuss the company's performance is scheduled for 1:15pm PT/4:15pm ET.

July 3, 2014

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on non-antibiotic anti-infectives, announced today that CEOLIVE.TV, an online service that delivers news about companies to...

July 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akashi announced that the Muscular Dystrophy Association has made an investment as part of a collective funding totaling $1.5 million to help fund clinical development of HT-100 for DMD.

July 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akashi Therapeutics announced that the FDA has granted Fast Track designation to the company’s most advanced product candidate, HT-100, for Duchenne muscular dystrophy (DMD).

July 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akashi Therapeutics presented preliminary positive clinical data for HT-100 for Duchenne muscular dystrophy (DMD) at the New Directions in Biology and Disease of Skeletal Muscle Conference.

July 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Lando and Anastasi, LLP (L&A) today announced that Cristin D. Berkey, Nathan A. Billings, Crystal Lee Kellas, and Angelyn Larkin have joined the firm. The Cambridge-based intellectual property law firm, one...

July 3, 2014

DARMSTADT, Germany--(BUSINESS WIRE)--Strong growth at Merck’s Consumer Health Division builds on 80 years of delivery

July 3, 2014

SAN DIEGO--(BUSINESS WIRE)--Batu Biologics announced today the appointment of Dr. Alan Lewis to the company’s Scientific Advisory Board, an experienced industry veteran with over 37 years of experience as an executive in life sciences. Dr. Lewis...

July 2, 2014

SALT LAKE CITY--(BUSINESS WIRE)--“Rich McKeown brings a deep understanding of the healthcare industry as the chief executive of one of the nation’s most respected healthcare consulting firms,” said ProLung President and CEO Steven Eror when he...

July 2, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea will host a webcast of an investor briefing to discuss the role of sentinel lymph node biopsy in head and neck cancers on Tuesday, July 8, 2014 with a guest speaker, Dr. Stephen Lai.

July 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bind Therapeutics announced today the completion of its collaborative research program with Amgen Inc. originally entered into in January 2013.

July 2, 2014

LAUSANNE, Switzerland--(BUSINESS WIRE)--U.S. Food & Drug Administration grants Orphan Drug Designation for Galderma’s trifarotene molecule in the treatment of congenital ichthyosis.

July 2, 2014

IRVING, Texas--(BUSINESS WIRE)--Two hundred twenty tons of new hope for cancer patients came to North Texas early today with the arrival of the massive cyclotron at the Texas Center for Proton Therapy. The center, a collaboration of Texas...

July 2, 2014

WASHINGTON--(BUSINESS WIRE)--A new optical system based on a commercial video projector, a single pixel sensor and a signal processing technique called compressive sensing is a first step toward enabling deeper tissue imaging.

July 2, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Histogenics Corporation, a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, today announced the appointment of Kathleen Large, R.N., M.S., to Vice...

July 2, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2014 before the market opens on Wednesday, July 23, 2014...

July 2, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Synchroneuron closes $20 million Series B funding round from sole-investor Morningside Technology Ventures Limited to support the continued development of Phase 2 asset SNC-102.

July 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today the election of Amy W. Schulman to its Board of Directors. Ms. Schulman is the former Executive Vice President...

July 2, 2014

CINCINNATI--(BUSINESS WIRE)--Ethicon Endo-Surgery (Ethicon) today announced the receipt of a Bronze International Design Excellence Awards (IDEA) from the Industrial Designers Society of America (IDSA) for innovation with ENSEAL® G2 Articulating...

July 2, 2014

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that the U.S. Environmental Protection Agency purchased five additional licenses of the Company's industry-leading GastroPlus and ADMET Predictor software programs.

July 2, 2014

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (NASDAQ:TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services,...

July 2, 2014

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides Inc. Director Professor Boniuk invested $5M into the Company in a Debenture agreement.

July 2, 2014

MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--RBCC Developing New Tech to Help Prevent Deaths from Prescription Overdoses

July 2, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--COPD: Boehringer Ingelheim today announced submission of Marketing Authorisation Applications in 31 European countries for the once-daily fixed-dose combination of tiotropium + olodaterol.

July 2, 2014

AMSTERDAM--(BUSINESS WIRE)--AIMM Therapeutics' partner MedImmune has started phase I clinical studies with a best-in-class antibody for the treatment of respiratory syncytial virus (RSV) infections in young, at risk children.

July 2, 2014

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife AB (STO:VITR): Invitation to attend Vitrolife’s conference call regarding presentation of the interim report for the period January - June 2014. The presentation will be held in...

July 2, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced it has entered into a definitive agreement to acquire Seragon Pharmaceuticals, Inc. (Seragon), a privately held...

July 1, 2014

NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX) today announced that it has closed a $45 million senior secured term loan facility, led by funds advised by Athyrium Capital Management. The term loan will mature in 2018 and has an...

July 1, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles has completed the acquisition of Encore Health Resources a leader in the health-information analytics and technology consulting services industry focused on healthcare providers.

July 1, 2014

BURLINGTON, Mass.--(BUSINESS WIRE)--Teratech Corporation today announced the launch of the new uSmart 3300 Ultrasound System, the second in Terason’s uSmart family of proprietary products released in the past year. This conventional portable...

July 1, 2014

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene (Paris:TNG) today announced that it was invited to present existing preclinical data on its proprietary program against chronic hepatitis B, TG1050 immunotherapy, at the BIT 5th...

July 1, 2014

ANN ARBOR, Mich.--(BUSINESS WIRE)--Truven Health Analytics™ Reports Integration of Micromedex® Patient Education and Clinical Decision Support into EMR Systems is on the Rise in Support of Meaningful Use Attestation

July 1, 2014

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb to Announce Results for Second Quarter on July 24

July 1, 2014

HAIFA, Israel--(BUSINESS WIRE)--Accellta granted worldwide non-exclusive rights to Miltenyi Biotec to use Accelta’s patents in manufacturing and commercialization of Miltenyi Biotec’s proprietary medium for stem cell cultivation

July 1, 2014

CINCINNATI--(BUSINESS WIRE)--BioRx will report respiratory health outcomes to physicians who prescribe treatment for alpha-1 antitrypsin deficiency.